News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spectral Molecular Imaging, Inc. Releases Investor Information Briefing on Company's Development of Advanced Devices for Cancer Detection and Other Applications



6/11/2010 12:19:21 PM

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies, Inc. (OTCBB: CSDT), has announced the availability of a new Investor Information Brief outlining the Company’s proprietary technology and its strategy to develop a line of optical imaging devices for earlier detection of cancer and other major disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES